Water → N-(1-((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)-2-methylpropan-2-yl)-2-(1H-imidazol-1-yl)isonicotinamide
反応式
[N:1]1([C:6]2[CH:7]=[C:8]([CH:12]=[CH:13][N:14]=2)[C:9]([OH:11])=O)[CH:5]=[CH:4][N:3]=[CH:2]1.C1C=CC2N(O)N=NC=2C=1.O.CCN=C=NCCCN(C)C.Cl.Cl.[NH2:39][C:40]1[C:41]2[C:51]([O:52][CH2:53][C:54]([NH2:57])([CH3:56])[CH3:55])=[CH:50][CH:49]=[CH:48][C:42]=2[NH:43][S:44](=[O:47])(=[O:46])[N:45]=1.C(N(CC)CC)C>CN(C=O)C>[NH2:39][C:40]1[C:41]2[C:51]([O:52][CH2:53][C:54]([NH:57][C:9](=[O:11])[C:8]3[CH:12]=[CH:13][N:14]=[C:6]([N:1]4[CH:5]=[CH:4][N:3]=[CH:2]4)[CH:7]=3)([CH3:55])[CH3:56])=[CH:50][CH:49]=[CH:48][C:42]=2[NH:43][S:44](=[O:47])(=[O:46])[N:45]=1参加物
反応物 6
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 50 °C
実験手順
To a solution of 2-(1H-imidazol-1-yl)isonicotinic acid (1.00 g, 5.29 mmol), in DMF (41 mL) at room temperature, was added HOBt.H2O (891 mg, 5.82 mmol), EDCI.HCl (1.11 g, 5.82 mmol), 4-amino-5-(2-amino-2-methylpropoxy)-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxide hydrochloride (1.70 g, 5.29 mmol) and triethylamine (1.54 mL, 11.1 mmol). The reaction was heated to 50° C. for one hour, and upon completion was cooled to room temperature, filtered and the filtrate was purified by HPLC (10-90% acetonitrile in water), then the purified product was washed in boiling ethanol for thirty minutes, then cooled to room temperature. The solid was collected by vacuum filtration, sodium carbonate (178 mg) in water (50 mL) was added and the mixture was heated to 60° C. until in solution, then was cooled to 0° C. and neutralized with hydrochloric acid (1N). The white solid was collected by vacuum filtration and dried under vacuum at 50° C. (295 mg). Sodium carbonate (87.3 mg) in water (7 mL) was added to the white solid and the mixture was heated to 60° C. until in solution. The warm solution was filtered, cooled to room temperature, and neutralized with hydrochloric acid (1N). The white solid was collected by vacuum filtration and dried under vacuum at 50° C. to yield N-(1-((4-amino-2,2-dioxido-1H-benzo[c][1,2,6]thiadiazin-5-yl)oxy)-2-methylpropan-2-yl)-2-(1H-imidazol-1-yl)isonicotinamide as a white solid (171 mg, 7% yield). 1H NMR (DMSO-d6, 400 MHz): δ 1.50 (s, 6H), 4.41 (s, 2H), 6.62 (d, J=8.0 Hz, 1H), 6.79 (d, J=8.0 Hz, 1H), 7.14 (s, 1H), 7.47 (t, J=8.4 Hz, 1H), 7.63 (dd, J=6.0 Hz, 1H), 7.81 (s, 1H), 8.00 (d, J=8.0 Hz, 1H), 8.47 (s, 1H), 8.58 (m, 3H), 11.00 (s, 1H). MS 456 (MH+).
後処理
- temperatureupon completion was cooled to room temperature
- filtrationfiltered
- customthe filtrate was purified by HPLC (10-90% acetonitrile in water)
- washthe purified product was washed
- customfor thirty minutes
- temperaturecooled to room temperature
- filtrationThe solid was collected by vacuum filtration, sodium carbonate (178 mg) in water (50 mL)
- additionwas added
- temperaturethe mixture was heated to 60° C. until in solution
- temperaturewas cooled to 0° C. and neutralized with hydrochloric acid (1N)
- filtrationThe white solid was collected by vacuum filtration
- customdried under vacuum at 50° C. (295 mg)
- additionSodium carbonate (87.3 mg) in water (7 mL) was added to the white solid
- temperaturethe mixture was heated to 60° C. until in solution
- filtrationThe warm solution was filtered
- temperaturecooled to room temperature
- filtrationThe white solid was collected by vacuum filtration
- customdried under vacuum at 50° C.
出典と根拠
- ORDレコード
- ord-b5933ecff91e47f9963df322e7f3408a
- 出典データセット
- uspto-grants-2016_06
- 特許番号
- US09371317B2
反応ノート
読み込み中…